Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (4539)	12/16/2005 10:22:59 AM
From: scaram(o)uche	Respond to of 4974

ah, ok, missed that. thanks! (eom)

To: rkrw who wrote (4539)	12/16/2005 11:36:39 AM
From: keokalani'nui	Read Replies (1) \| Respond to of 4974

rkrw, Did you ever look at the new cgtk? I owned cgtk all year, just about, and when I looked at the post-algrx company I sold it all. I decided I had no clue what is the margin or how big the market for the pedi-lidocaine; and I almost but not quite buy the hype on the eczema trial (if cgtk firmly believed in it themselves they wouldn't have done this deal). Plus they never responded to my eMail about the aria nf-kb IP. Finally, the capcaisin program is too early to tell. You ever give it glance? W